Saxon; Andrew

Patent Applications and Registrations

Patent applications and USPTO patent grants for Saxon; Andrew.The latest application filed is for "therapeutic anti-ige antibodies and methods and compositions thereof".

Company Profile

1.8.11

Saxon; Andrew - Santa Monica CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Therapeutic Anti-IgE Antibodies and Methods and Compositions Thereof App 20190322766 - Saxon; Andrew ; et al.	2019-10-24
Anti-immunoglobulin E antibodies and methods of using thereof Grant 10,196,458 - Zhang , et al. Fe	2019-02-05
Anti-Immunoglobulin E Antibodies and Methods of Using Thereof App 20160168268 - Zhang; Ke ; et al.	2016-06-16
Fusion Molecules And Methods For Treatment Of Immune Diseases App 20120148585 - Saxon; Andrew	2012-06-14
Fusion molecules and treatment of IgE-mediated allergic diseases Grant 7,879,334 - Saxon , et al. February 1, 2	2011-02-01
Fusion molecules and methods for treatment of immune diseases Grant 7,879,324 - Saxon February 1, 2	2011-02-01
Ige Directed Dna Vaccination App 20110020373 - Saxon; Andrew ; et al.	2011-01-27
Fusion Molecules And Methods For Treatment Of Immune Diseases App 20090317389 - Saxon; Andrew	2009-12-24
Modified Fusion Molecules For Treatment Of Allergic Disease App 20090136493 - Saxon; Andrew ; et al.	2009-05-28
Fusion molecules and methods for treatment of immune diseases Grant 7,534,440 - Saxon May 19, 2	2009-05-19
Modified fusion molecules for treatment of allergic disease Grant 7,488,804 - Saxon , et al. February 10, 2	2009-02-10
Fusion molecules and treatment of IgE-mediated allergic diseases Grant 7,265,208 - Saxon , et al. September 4, 2	2007-09-04
Modified fusion molecules for treatment of allergic disease App 20060171942 - Saxon; Andrew ; et al.	2006-08-03
Method for determining susceptibility of an individual to allergen induced hypersensitivity App 20060154261 - Saxon; Andrew ; et al.	2006-07-13
Fusion molecules and treatment of IgE-mediated allergic diseases App 20030082190 - Saxon, Andrew ; et al.	2003-05-01
Fusion molecules and methods for treatment of immune diseases App 20030064063 - Saxon, Andrew	2003-04-03
Immunoglobulin class switch recombination App 20030059763 - Saxon, Andrew ; et al.	2003-03-27
IgE isoforms and methods of use Grant 6,043,345 - Saxon , et al. March 28, 2	2000-03-28
Immunoglobulin trans-spliced transcripts and uses thereof Grant 6,030,830 - Saxon , et al. February 29, 2	2000-02-29

Company Registrations

NCAGE Code	50KJ6	SAXON, ANDREW
CAGE Code	50KJ6	SAXON, ANDREW
S.A.M. Registration	50KJ6 [806829615]	SAXON, ANDREW

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.